We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Three European associations, including the European Association of Percutaneous Cardiovascular Interventions and the Working Group on Thrombosis of the European Society of Cardiology, have issued a consensus document today that advocates for a radial-first approach for PCI.
The paper, which was published today in EuroIntervention and includes input from the Acute Cardiovascular Care Association, provides an evidence-based view on the technical, clinical and organizational implications of using the radial access for coronary angiography and interventions, including advantages, disadvantages and expertise requirements.
The authors cite meta-analyses of randomized studies, including the RIVAL and RIFLE trials, which show a reduction in access site-related major bleeding for radial vs. femoral access. In addition, they mention one meta-analysis and several observational studies that suggest a reduction in vascular access-site complications and site-related major bleeds with radial access might improve patient outcomes.
However, since there is a small percentage of patients in whom the radial approach does not work, the consensus document also emphasizes the importance of maintaining expertise in the femoral approach. “All radial-proficient teams should aim to maintain optimal proficiency in femoral procedures as well. Some low-risk patients for femoral access site complications and procedures requiring femoral access ([intra-aortic balloon pump], radial access failure or if guiding catheters ≥8F are required) should provide a volume of cases to maintain adequate training in femoral artery puncture,” the researchers wrote.
In an accompanying press release, Ferdinand Kiemeneij, MD, inventor of radial access for PCI and a co-author of the document, said although this technique was initiated 20 years ago, there is still a lot going on to get everyone performing this procedure.
“It is taking off quite rapidly now and … this paper really adds to a more general acceptance of the technique,” said Kiemeneij, who is with the department of interventional cardiology at Onze Lieve Vrouwe Gasthuis in Amsterdam, the Netherlands. “I’m convinced that it will improve patient care overall by providing more knowledge, more training and better awareness.”
Disclosure: Kiemeneij receives Kimny catheter sales royalties from Boston Scientific. All other researchers report no relevant financial disclosures.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.